New Market Research Report: Bahrain Pharmaceuticals & Healthcare Report Q4 2014

Bahrain's pharmaceutical market ou tlook over the medium- and long- term remain bullish despite recent price cuts made to a v ariety of medicines across the country , contributing to only moderate growth in the short term. Longer term, t he country's ageing population, increasing chronic diseases bu rden and robust economic growth will drive medicine demand; h owever, further medicine price cuts, lower-than-expected oil prices in coming years and failure to find a lasting solution to the political crisis present challenges that will negatively impact market growth potential.

Headline Expenditure Projections

* Pharmaceuticals: BHD106mn (USD281mn) in 2013 to BHD114mn (USD302mn) in 2014; +7.4% in both local currency and US dollar terms. Forecast in line with last quarter .
* Healthcare: BHD488mn (USD1.29bn) in 2013 to BHD533mn (USD1.41bn) in 2014; +9.4% in both local currency and US dollar terms. Forecast in line with last quarter.

Risk/Reward Rating: In our Q4 2014 matrix for the Middle East and Africa, Bahrain scores of 51.3 out of 100 (up from last quarter's score of 45.0) and is ranked 8th (up four places from Q314) out of the 31 markets surveyed in the region. The country's position is propped up by its favourable risks profile, as its longer-term rewards potential remains weighed down by its small population. On the other hand, Bahrain's well-developed business environment and demographic and epidemiological trends will continue to provide commercial opportunities for innovative drugmakers.

Full Report Details at
- http://www.fastmr.com/prod/878940_bahrain_pharmaceuticals_healthcare_report_q4_2014.aspx?afid=301

Key Trends And Developments

August

On August 12, Health officials paid a visit to Central Governorate on the behalf of Health Minister, Sadiq Abdulkarim Al-Shehabi to communicate with its citizens and listen to their complaints and suggestions. Also discussed were the main health services and projects on the agenda of Health Ministry, including the establishment of physiotherapy centre in Hamad Kanoo Health Centre, expansion work in Hamad Kanoo...

The Bahrain Pharmaceuticals & Healthcare Report features Business Monitor International (BMI)'s forecasts for drugs and healthcare expenditure and imports and exports, focusing on the growth outlook for the prescription, OTC, patented drugs and generics market segments.

BMI's Bahrain Pharmaceuticals & Healthcare Report provides industry professionals, strategists, company executives, investors, analysts and sales/marketing heads with independent forecasts and competitive intelligence on the Bahraini pharmaceutical and healthcare industry.

Key Benefits

* Benchmark BMI's independent pharmaceutical and healthcare industry forecasts for Bahrain to test other views - a key input for successful budgeting and strategic business planning in the Bahraini pharmaceutical and healthcare market.

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

You may also be interested in these related reports:

- South Korea Pharmaceuticals & Healthcare Report Q4 2014
- Sweden Pharmaceuticals & Healthcare Report Q4 2014
- Kenya Pharmaceuticals & Healthcare Report Q4 2014
- Argentina Pharmaceuticals & Healthcare Report Q4 2014
- Peru Pharmaceuticals & Healthcare Report Q4 2014